| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/24/2010 | CA2747064A1 Monoclonal antibodies directed against lg4/5 domain of alpha3 chain of human laminin-5 |
| 06/24/2010 | CA2745972A1 Conjugates comprising nanoparticles coated with platinum containing compounds |
| 06/24/2010 | CA2745459A1 Thiazoles as cannabinoid receptor ligands |
| 06/24/2010 | CA2744624A1 Antibodies against human angiopoietin 2 |
| 06/24/2010 | CA2743433A1 Anti-cmet antibody |
| 06/24/2010 | CA2706317A1 Doc1 compositions and methods for treating cancer |
| 06/23/2010 | EP2199793A1 Method of evaluating human dendritic cells and human cell immunotherapeutic agent |
| 06/23/2010 | EP2199390A1 Anti-epha2 antibody |
| 06/23/2010 | EP2199299A2 Antisense modulation of survivin expression |
| 06/23/2010 | EP2199292A1 7-azaindirubins, 7'-azaindirubins, 7-7'-diazaindirubin and the corresponding 3'-oxime ether derivates: production thereof, their production and use as a medicament |
| 06/23/2010 | EP2199284A1 Pharmaceutical composition for inhibiting accumulation of amyloid- beta protein |
| 06/23/2010 | EP2198891A1 Method for promoting the expression of p53, and p53 expression promoter for use in the method |
| 06/23/2010 | EP2198884A1 Monoclonal antibodies directed against LG4-5 domain of alpha3 chain of human laminin-5 |
| 06/23/2010 | EP2198879A1 CD74 modulator agent for regulating dendritic cell migration and device for studying the motility capacity of a cell |
| 06/23/2010 | EP2198878A1 Polypeptide bombesin antagonists |
| 06/23/2010 | EP2198872A1 Use of corrinoids for the treatment of skin diseases. |
| 06/23/2010 | EP2198867A1 Pyrimidine-based compounds useful as GSK-3 inhibitors |
| 06/23/2010 | EP2198863A1 Cancer treatment with gamma-secretase inhibitors |
| 06/23/2010 | EP2198041A1 Method and composition for cancer diagnosis and treatment |
| 06/23/2010 | EP2198021A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 06/23/2010 | EP2197918A1 Combination therapy with type i and type ii anti-cd20 antibodies |
| 06/23/2010 | EP2197909A2 Receptor-targeting reagents |
| 06/23/2010 | EP2197897A1 Amino acid pairing-based self assembling peptides and methods |
| 06/23/2010 | EP2197886A1 5-cyano-thienopyridines for the treatment of tumors |
| 06/23/2010 | EP2197880A1 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors |
| 06/23/2010 | EP2197878A2 Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases |
| 06/23/2010 | EP2197876A1 Thiazole and oxazole kinase inhibitors |
| 06/23/2010 | EP2197874A1 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine compounds and their use |
| 06/23/2010 | EP2197858A2 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same |
| 06/23/2010 | EP2197854A1 A new class of histone deacetylase inhibitors |
| 06/23/2010 | EP2197552A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 06/23/2010 | EP2197495A2 Lipopeptides for delivery of nucleic acids |
| 06/23/2010 | EP2197477A2 Use of lvv-hemorphin-6 and optionally af12198 as therapeutic agent(s) |
| 06/23/2010 | EP2197474A1 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis |
| 06/23/2010 | EP2197470A2 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197466A2 Use of retrocyclin-1 as a therapeutic agent for the treatment of hcmv infections |
| 06/23/2010 | EP2197462A2 Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent |
| 06/23/2010 | EP2197279A1 C10-substituted camptothecin analogs |
| 06/23/2010 | EP2197274A1 Azacytidine analogues and uses thereof |
| 06/23/2010 | EP2024372B1 Thieno[3,2-d]pyrimidine derivative useful as pi3k inhibitor |
| 06/23/2010 | EP2024335B1 Novel imidazole derivatives, preparation and user thereof as medicine |
| 06/23/2010 | EP1910288B1 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 06/23/2010 | EP1699782B1 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 06/23/2010 | EP1670514B1 Antitumor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor |
| 06/23/2010 | EP1608400B1 Elevation of adenosine level by cytokine-induced expression of cd73 |
| 06/23/2010 | EP1553911B1 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer |
| 06/23/2010 | EP1511734B1 Compounds, compositions, and methods |
| 06/23/2010 | EP1416959B1 Liposomes prepared from the extractable lipids from a mycobacterium |
| 06/23/2010 | EP0790835B2 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector |
| 06/23/2010 | CN1993130B Processes and intermediates used for preparing fused heterocyclic kinase inhibitors |
| 06/23/2010 | CN1926133B Epothilone derivatives |
| 06/23/2010 | CN1919258B Application of schisandra chinensis in the preparation of medicine for preventing and reducing toxic and side effect of antitumor agent |
| 06/23/2010 | CN1910176B Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 06/23/2010 | CN1871256B Muteins of tear lipocalin |
| 06/23/2010 | CN1809378B Methods for inhibiting viral replication in vivo |
| 06/23/2010 | CN1796400B Extractive of phytosterol extracted from bamboo shoot, preparation method and application |
| 06/23/2010 | CN1655827B Novel use of adenoviruses and nucleic acids coding therefor |
| 06/23/2010 | CN101754979A Monoclonal antibodies for treatment of cancer |
| 06/23/2010 | CN101754978A The ED-A antigen of fibrinogen is associated with the neovas culature of tumor metastases |
| 06/23/2010 | CN101754968A Substituted imidazopyridazines as PI3K lipid kinase inhibitors |
| 06/23/2010 | CN101754967A benzimidazole poly(adp-ribose)polymerase inhibitors |
| 06/23/2010 | CN101754965A CSF-1R inhibitors, compositions, and methods of use |
| 06/23/2010 | CN101754964A dna pk inhibitors |
| 06/23/2010 | CN101754956A Substituted indazole derivatives active as kinase inhibitors |
| 06/23/2010 | CN101754955A Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |
| 06/23/2010 | CN101754771A Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 06/23/2010 | CN101748122A Disturbing molecule for inhibiting expression of TM4SF4 and application thereof |
| 06/23/2010 | CN101747451A Targeted adhesion chitosan material and application thereof |
| 06/23/2010 | CN101747437A Apoptin-EC-SOD carboxyl terminal protein transduction domain fusion protein |
| 06/23/2010 | CN101747423A Centipede anti-tumor active protein |
| 06/23/2010 | CN101747411A Aminoacyl tryptophyl tryptophan tripeptide benzyl ester as well as preparation method and application thereof |
| 06/23/2010 | CN101747405A Berberine glycyrrhizic acid enantiomer salt and preparation method and usage thereof |
| 06/23/2010 | CN101747404A Glycyrrhetinic acid cyclic phosphonate ester derivative and preparation method thereof |
| 06/23/2010 | CN101747400A Lanostane type triterpenoid with anti-tumor activity, preparation method and application |
| 06/23/2010 | CN101747384A 5-chlorine salicylyl hydrazine triphenyltin chloride coordination compound, as well as preparation method and application thereof |
| 06/23/2010 | CN101747382A Ruthenium polypyridyl complex using quinolones compound as ligand, preparation method and application thereof |
| 06/23/2010 | CN101747354A Dipeptide boronic acids consisting of beta amino acids, ester compounds and preparation methods and uses thereof |
| 06/23/2010 | CN101747353A N'-(3-nitrobenzoyl)-N-salicylyl hydrazne copper complex as well as preparation method and application thereof |
| 06/23/2010 | CN101747339A 1'-thio-aza indirubin compound, application and preparation method thereof |
| 06/23/2010 | CN101747330A Pyridyl thiazole amines compound, as well as medical composite and application thereof |
| 06/23/2010 | CN101747329A 4-arylthioquinazoline derivatives and preparation methods and pharmaceutical uses thereof |
| 06/23/2010 | CN101747326A 18- or 14-macrolide epothilone compound and application thereof |
| 06/23/2010 | CN101747324A Sulfonamide derivatives |
| 06/23/2010 | CN101747300A Mutual prodrug and preparation method based on paclitaxel and nitrogen mustard |
| 06/23/2010 | CN101747271A Method for preparing polysubstituted isoquinoline compounds |
| 06/23/2010 | CN101747190A Bisabolane sesquiterpene compound and preparation method and application thereof |
| 06/23/2010 | CN101747170A Conjugated type coenzyme Q analogue, preparation method and application thereof |
| 06/23/2010 | CN101745123A Method for preparing anti-cancer medicament capable of carrying out automatic synthesis and target release |
| 06/23/2010 | CN101745122A Automatic synthesis anti-cancer drug preparation method based on microfluidic chip |
| 06/23/2010 | CN101745121A Genetic therapy breast cancer drug preparation method based on microfluidic chip |
| 06/23/2010 | CN101745120A Application of miRNA-320 in preparing preparation for promoting apoptosis of tumor cells |
| 06/23/2010 | CN101745111A Method for restraining infiltration and metastasis of breast cancer cells by using target CCL 18 and application thereof |
| 06/23/2010 | CN101745089A Medicament for treating stomach cancer and preparation method thereof |
| 06/23/2010 | CN101745080A Chinese patent medicine for treating leukemia |
| 06/23/2010 | CN101745077A Compound Chinese medicinal preparation for treating fatty liver, alcoholic hepatitis and complications |
| 06/23/2010 | CN101745065A Pharmaceutical composition with effects of resisting cancer and alleviating pain |
| 06/23/2010 | CN101745064A Cancer pain killing paste |
| 06/23/2010 | CN101745063A Chinese patent medicine for resisting cancer |
| 06/23/2010 | CN101745052A Medicament for treating tumors and preparation method thereof |
| 06/23/2010 | CN101745046A Medicine for treating malignant tumors and preparation method thereof |